General information

DATEThursday 22 September 2016

VENUEZaalverhuur 7Boothstraat 7 3512 BT, Utrecht T: +31 (0)30-751 6113

TARGET AUDIENCEThe meeting is designed for medical microbiologists,hospital pharmacists, infectious disease specialists and all those with interests in medical mycology.

ACCREDITATIONAccreditation applied with:• Nederlandse Internisten Vereniging (NIV)• Nederlandse vereniging voor Medische Microbiologie (NVMM)• Nederlandse Vereniging van Ziekenhuis Apothekers (NVZA)

REGISTRATION AND PAYMENT Registration is possible via the conference website www.nvmy.nl or www.congresscare.com. Payment can be done online by: creditcard or SEPA direct debit.

NVMy member 95 EURMedical specialist & scientifi c delegates 175 EUR CANCELLATION Cancellations and refund requests must be submitted in writing to the congress secretariat. Cancellations made before 22 August 2016 will be refunded minus 30% to cover administration costs. After this date no refunds will be given. All refunds will be made after the congress.

SYMPOSIUM SECRETARIAT

Congress CarePO Box 440NL-5201 AK ‘s-HertogenboschT: +31 (0)73 690 1415info@congresscarewww.congresscare.com

22 September 2016ZAALVERHUUR 7, UTRECHT

THE NETHERLANDS

www.nvmy.nl

Mycology UpdateA SYMPOSIUM OF THE NETHERLANDS

SOCIETY OF MEDICAL MYCOLOGY

Invitation

Medical mycology is a rapidly evolving area and this symposium will highlight recent developments from laboratory bench to patient bedside.

New taxonomy challenges our ability to correctly identify clinical fungi and new techniques are becoming available which may help us overcome these challenges.

Also our understanding of intrinsic and acquired resistance has increased and in vitro susceptibility testing is often needed to help guide antifungal therapy choices.

New drugs and new formulations have become available and offer us more options in patient treatment.

Also new guidelines have been published, that provide evidence-based recommendations for management of Candida and Aspergillus infections. Specifi c topics related to our daily practice will be discussed including invasive aspergillosis as complication of infl uenza in ICU-patients, the latest trends in azole resistance and Cryptococcus gattii epidemiology. Furthermore, the increasing trend of Fusarium keratitis will be presented.

National and international experts will share their insights with us and provide an interesting and stimulating day for those involved in clinical management as well as laboratory diagnosis of invasive fungal diseases.

PROGRAM COMMITTEEProf. dr. Paul VerweijProf. dr. Sybren de HoogDr. Jacques F. MeisDr. Ferry Hagen

Mycology Update 1 - Program

09:00 Welcome and registration UPDATES FROM THE MYCO LAB09:30 Fungal taxonomy Prof. dr. Sybren de Hoog, CBS Biodiversity Center, Utrecht, Netherlands09:50 Conventional mycology Ton Rijs, Radboud University Medical Center, Nijmegen, Netherlands 10:30 Break 11:00 New non culture-based techniques Prof. dr. Katrien Lagrou, University Hospitals Leuven, Belgium11:20 Susceptibility and breakpoints Dr. Joseph Meletiadis, Erasmus Medical Center, Rotterdam, Netherlands11:40 Interactive cases – I Residents in medical microbiology 12:30 Lunch UPDATES: NEW ANTIFUNGALS AND GUIDELINES13:30 Isavuconazole Prof. dr. Johan Maertens, University Hospitals Leuven, Belgium13:50 Posaconazole Dr. Roger Brüggemann, Radboud University Medical Centre, Nijmegen, Netherlands14:10 New guidelines Prof. dr. Andrew Ullmann, Universitätsklinikum Würzburg, Germany 14:40 Break

UPDATES: EPIDEMIOLOGY15:10 Post infl uenza invasive aspergillosis Prof. dr. Paul Verweij, Radboud University Medical Centre, Nijmegen, Netherlands15:30 Azole resistance in Aspergillus fumigatus Dr. Jacques Meis, Canisius Wilhelmina Hospital, Nijmegen, Netherlands15:50 Cryptococcus gattii Dr. Ferry Hagen, Canisius Wilhelmina Hospital, Nijmegen, Netherlands16:10 Fusarium keratitis Dr. Cathrien Eggink, Radboud University Medical Centre, Nijmegen, Netherlands16:30 Interactive cases – II Residents in medical microbiology 17:10 Drinks